81 related articles for article (PubMed ID: 23397711)
1. [Application of BeWo cell model in studies on placental transport mechanism].
Guo J; Song DR
Zhongguo Zhong Yao Za Zhi; 2012 Nov; 37(21):3193-7. PubMed ID: 23397711
[TBL] [Abstract][Full Text] [Related]
2. Efflux transporter mRNA expression profiles in differentiating JEG-3 human choriocarcinoma cells as a placental transport model.
Ikeda K; Yamasaki K; Homemoto M; Yamaue S; Ogawa M; Nakao E; Fukunaga Y; Nakanishi T; Utoguchi N; Myotoku M; Hirotani Y
Pharmazie; 2012 Jan; 67(1):86-90. PubMed ID: 22393837
[TBL] [Abstract][Full Text] [Related]
3. Uptake mechanism of valproic acid in human placental choriocarcinoma cell line (BeWo).
Ushigome F; Takanaga H; Matsuo H; Tsukimori K; Nakano H; Ohtani H; Sawada Y
Eur J Pharmacol; 2001 Apr; 417(3):169-76. PubMed ID: 11334847
[TBL] [Abstract][Full Text] [Related]
4. Selective impairment of taurine transport by cyclosporin A in a human placental cell line.
Ramamoorthy S; Leibach FH; Mahesh VB; Ganapathy V
Pediatr Res; 1992 Jul; 32(1):125-7. PubMed ID: 1378960
[TBL] [Abstract][Full Text] [Related]
5. Transport and metabolism of opioid peptides across BeWo cells, an in vitro model of the placental barrier.
Ampasavate C; Chandorkar GA; Vande Velde DG; Stobaugh JF; Audus KL
Int J Pharm; 2002 Feb; 233(1-2):85-98. PubMed ID: 11897413
[TBL] [Abstract][Full Text] [Related]
6. The BeWo choriocarcinoma cell line as a model of iodide transport by placenta.
Manley SW; Li H; Mortimer RH
Placenta; 2005 May; 26(5):380-6. PubMed ID: 15850642
[TBL] [Abstract][Full Text] [Related]
7. Alteration of integrins under hypoxic stress in early placenta and choriocarcinoma cell line BeWo.
Iwaki T; Yamamoto K; Matsuura T; Sugimura M; Kobayashi T; Kanayama N
Gynecol Obstet Invest; 2004; 57(4):196-203. PubMed ID: 14963368
[TBL] [Abstract][Full Text] [Related]
8. Characterization of glucose transport and glucose transporters in the human choriocarcinoma cell line, BeWo.
Shah SW; Zhao H; Low SY; Mcardle HJ; Hundal HS
Placenta; 1999 Nov; 20(8):651-9. PubMed ID: 10527819
[TBL] [Abstract][Full Text] [Related]
9. Comparison of folic acid uptake characteristics by human placental choriocarcinoma cells at acidic and physiological pH.
Keating E; Lemos C; Azevedo I; Martel F
Can J Physiol Pharmacol; 2006 Feb; 84(2):247-55. PubMed ID: 16900951
[TBL] [Abstract][Full Text] [Related]
10. Assessment of an in vitro transport model using BeWo b30 cells to predict placental transfer of compounds.
Li H; van Ravenzwaay B; Rietjens IM; Louisse J
Arch Toxicol; 2013 Sep; 87(9):1661-9. PubMed ID: 23689295
[TBL] [Abstract][Full Text] [Related]
11. JAR human placental choriocarcinoma cells actively synthesize, take up and release polyamines.
Fontana L; Cravanzola C; Colombatto S; Grillo MA
Cell Biochem Funct; 1996 Sep; 14(3):173-80. PubMed ID: 8888570
[TBL] [Abstract][Full Text] [Related]
12. Functional characterization of L-alanine transport in a placental choriocarcinoma cell line (BeWo).
Moe AJ; Furesz TC; Smith CH
Placenta; 1994 Dec; 15(8):797-802. PubMed ID: 7886021
[TBL] [Abstract][Full Text] [Related]
13. Oxidative stress stimulates α-tocopherol transfer protein in human trophoblast tumor cells BeWo.
Etzl RP; Vrekoussis T; Kuhn C; Schulze S; Pöschl JM; Makrigiannakis A; Jeschke U; Rotzoll DE
J Perinat Med; 2012 Feb; 40(4):373-8. PubMed ID: 22752767
[TBL] [Abstract][Full Text] [Related]
14. In vitro placental model optimization for nanoparticle transport studies.
Cartwright L; Poulsen MS; Nielsen HM; Pojana G; Knudsen LE; Saunders M; Rytting E
Int J Nanomedicine; 2012; 7():497-510. PubMed ID: 22334780
[TBL] [Abstract][Full Text] [Related]
15. Studying placental transfer of highly purified non-dioxin-like PCBs in two models of the placental barrier.
Correia Carreira S; Cartwright L; Mathiesen L; Knudsen LE; Saunders M
Placenta; 2011 Mar; 32(3):283-91. PubMed ID: 21236486
[TBL] [Abstract][Full Text] [Related]
16. IGF regulation of neutral amino acid transport in the BeWo choriocarcinoma cell line (b30 clone): evidence for MAP kinase-dependent and MAP kinase-independent mechanisms.
Fang J; Mao D; Smith CH; Fant ME
Growth Horm IGF Res; 2006; 16(5-6):318-25. PubMed ID: 17035059
[TBL] [Abstract][Full Text] [Related]
17. TMED2/p24β1 is expressed in all gestational stages of human placentas and in choriocarcinoma cell lines.
Zakariyah A; Hou W; Slim R; Jerome-Majewska L
Placenta; 2012 Mar; 33(3):214-9. PubMed ID: 22212250
[TBL] [Abstract][Full Text] [Related]
18. Expression of mTOR and downstream signalling components in the JEG-3 and BeWo human placental choriocarcinoma cell lines.
Mparmpakas D; Zachariades E; Foster H; Kara A; Harvey A; Goumenou A; Karteris E
Int J Mol Med; 2010 Jan; 25(1):65-9. PubMed ID: 19956903
[TBL] [Abstract][Full Text] [Related]
19. Expression of membrane and nuclear progesterone receptors in two human placental choriocarcinoma cell lines (JEG-3 and BeWo): Effects of syncytialization.
Zachariades E; Foster H; Goumenou A; Thomas P; Rand-Weaver M; Karteris E
Int J Mol Med; 2011 Jun; 27(6):767-74. PubMed ID: 21455559
[TBL] [Abstract][Full Text] [Related]
20. Expression and activity of vitamin D receptor in the human placenta and in choriocarcinoma BeWo and JEG-3 cell lines.
Pospechova K; Rozehnal V; Stejskalova L; Vrzal R; Pospisilova N; Jamborova G; May K; Siegmund W; Dvorak Z; Nachtigal P; Semecky V; Pavek P
Mol Cell Endocrinol; 2009 Feb; 299(2):178-87. PubMed ID: 19133314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
